What 10vc does

10vc (legal entity: TenVC) is a Menlo Park, California-based venture capital firm that invests at the pre-seed and seed stages in early-stage companies building breakthrough technologies. The firm positions itself around a thesis of backing "brilliant founders" developing transformational platforms across four verticals: Breakthrough Applications of Deep Science (biomanufacturing, synthetic biology, AI/ML for life sciences), the Industrial New Normal (exponential automation, advanced manufacturing, autonomous machines, fintech/insurtech), New Infrastructure & Tools (advanced computing, big data, development tools), and Global Strategic Areas & Megatrends (cybersecurity, defense, energy transition, longevity, space tech).

The firm is led by two partners, Ben Patterson and Daniel Ramirez. Patterson brings a decade-plus track record of early-stage investing with prior outcomes including Remitly, Luminar, Aurora Solar, Maxwell, Anduril, Loom, and Twelve. Ramirez brings prior operating and investing experience at LEO Pharma, The Coca-Cola Company, and McKinsey. The firm's stated value-add beyond capital is structured access to a strategic network of industry leaders, functional experts (Growth, Branding/Marketing, Product Management, Supply Chain, IT, HR), and technology specialists (Analytics, AI, Imaging, Hardware, Data/Cloud, Genetics Biomanufacturing), sourced through scouting teams across USA Research Labs, the EU, Israel, Canada, Accelerators, Incubators, and Micro VCs.

The portfolio spans at least 20 companies across AI-native process automation (BackOps, Pharmesol, Myriad, Quil, Approveit, DataDasher, heyData, EZee Assist), AI hardware and speech (Incept), frontier science (Cortex for quantum-controlled fusion, RadarTx for RNA-editing therapeutics, Cascade for cell-free biomanufacturing, Acorn Genetics), insurance technology (Sola), fintech compliance (Givecard), and consumer platforms (Humans Anonymous, Clearspace). The firm earns returns through equity investments at the earliest stages, monetizing via liquidity events (acquisitions or IPOs) on portfolio companies and corresponding carried interest on successful exits. Revenue, AUM, and fund economics are not publicly disclosed.

Name

10vc

Legal name

TenVC

Website

https://10vc.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

10vc is a Menlo Park-based venture capital firm investing at pre-seed and seed stages in breakthrough technologies. Led by partners Ben Patterson and Daniel Ramirez, it backs founders across AI, synthetic biology, biotech, fintech, insurtech, and quantum fusion.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Funds, Trusts, and Other Financial Vehicles (525)

SIC

Miscellaneous Business Credit Institution (6159)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

akta.pro secondary industries

Corporate Deep Tech / R&D Commercialization CVC (FSANAHAL), Joint Venture CVC / Consortium Funds (Multi-corporate) (FSANAHAE)

Keywords

• Venture capital investing
• Seed stage funding
• Pre-seed investments
• Early-stage startups
• Deep tech venture

Headquarters

HQ city

Menlo Park

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Investment Returns / Carried Interest: 10vc generates returns through equity investments in early-stage startups. The firm earns returns when portfolio companies achieve liquidity events through acquisitions or IPOs, typically through carried interest on successful exits.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

10vc is a venture capital firm that invests at pre-seed and seed stages in brilliant founders building breakthrough technologies that can scale into transformational platforms. The firm provides equity capital alongside strategic network access, functional expertise, and technology specialist support to help accelerate and de-risk portfolio companies from their first meeting forward.

Product overview

10vc is a venture capital firm that invests in brilliant founders building breakthrough technologies across multiple sectors. The portfolio includes a diverse set of AI-native platforms and products: BackOps offers an AI operating system for supply chain management with products AI Process Center and Relay; Pharmesol provides AI automation for pharmacy teams; Myriad automates regulatory compliance; Incept delivers voice AI for restaurants; Quil offers AI note-taking for recruiting; Approveit provides AI workflow automation; DataDasher offers AI assistance for financial analysts; heyData automates data protection compliance; EZee Assist provides franchise AI assistance; Cortex focuses on quantum-controlled fusion energy; RadarTx develops precision-targeted RNA-based therapies; Acorn Genetics offers genetics sequencing; Sola provides insurance technology; Humans Anonymous is a mental health audio platform; Givecard offers reloadable card issuance; Clearspace provides productivity nudging technology; and Cascade focuses on cell-free biomanufacturing enzymes.

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-Seed and Seed Stage Venture Capital Investment Equity capital investments in early-stage startups at pre-seed and seed stages, targeting brilliant founders building breakthrough technologies with potential to scale into transformational platforms. Offered to early-stage startup founders across deep science, industrial automation/AI, infrastructure and tools, and global strategic megatrends.
• Strategic Network and Functional Expertise Support Portfolio company support providing access to industry leaders, functional experts (Growth, Branding/Marketing, Product Management, Supply Chain, IT, HR), and technology specialists (Analytics, AI, Imaging, Hardware, Data/Cloud, Genetics Biomanufacturing) to accelerate growth and de-risk early-stage ventures. Offered to portfolio company founders as part of the investment relationship.

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability11 records

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Lux Capital: Early-stage venture firm focused on deep tech, frontier science, AI, and biotech — directly comparable to 10vc's deep science and industrial new normal verticals.
• DCVC (Data Collective): Seed and early-stage fund investing in deep tech, AI/ML, computational biology, and advanced computing — overlapping directly with 10vc's 'New Infrastructure & Tools' and Deep Science focus.
• Khosla Ventures: Large seed-to-growth fund with heavy emphasis on deep tech, biotech, clean energy, and AI — comparable to 10vc's portfolio construction across deep science and strategic megatrends.
• Founders Fund: Early-stage firm backing frontier technology, defense, biotech, and aerospace — overlapping with 10vc's strategic areas (cybersecurity/defense, space, longevity).
• Obvious Ventures: Early-stage venture firm investing in purpose-driven founders across health, sustainability, and economic empowerment — comparable to 10vc's Profitable Sustainability and Longevity themes.
• Collaborative Fund: Seed-stage fund focused on emerging technologies and sustainable businesses — comparable in stage and thematic breadth to 10vc's seed-first approach.
• Susa Ventures: Seed-stage venture firm investing in software, fintech, and emerging tech — overlaps with 10vc's Insurtech/Fintech and AI/automation portfolio.
• Lerer Hippeau: Seed-stage venture firm backing founders across consumer, software, and frontier tech — comparable in stage and breadth to 10vc.

Broad incumbents

• Andreessen Horowitz (a16z): Large multi-stage venture firm with dedicated AI, bio, and infrastructure franchises — broader incumbent overlapping with 10vc's verticals but at much later stages and AUM scale.
• Bain Capital Ventures: Multi-stage venture arm of Bain Capital investing across application software, fintech, and infrastructure — broader incumbent overlapping with 10vc's fintech/insurtech and infrastructure themes.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments26 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 10vc